Immucell ICCC Earnings Call Transcripts

NASDAQ ICCC
$10.22 +0.42 (+4.29%)
At close: Nov 9, 2026 · 4:00 PM EST
3 earnings calls on file for Immucell, from Q2 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Immucell Q2 2026 Earnings Call

Aug 14, 2026 4,254 words · 18 min read
  • Joe DiazInvestor Relations
  • Oliver Te BoekhorstPresident and Chief Executive Officer
  • Timothy FioriChief Financial Officer
  • Bobbi BrockmannSenior Vice President of Sales and Marketing
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Immucell Earnings Call Transcripts

Calls3
LatestAug 14, 2026
SinceQ2 2025

Fiscal 2026

Fiscal 2025

All 3 Immucell transcripts Register to get access to Immucell’s earnings call transcripts.